|
GeneEd develops new Therapeutic Area e-Learning curricula for the
Pharmaceutical Industry covering Oncology and the Urinary System
San Francisco, CA, December 3, 2002—
- GeneEd, Inc., the leading provider of advanced e-Learning solutions for the life science industry, today announced that it has released 36 new e-Learning courses in two important therapeutic areas that are relevant to the life science and healthcare industries: Oncology and The Urinary System. The comprehensive GeneEd Therapeutic Area curricula released today, in addition to the 77 courses in six additional therapeutic areas released over the last quarter, represent significant areas of focus for research, product development, and sales in major global pharmaceutical organizations. It is critical that pharmaceutical employees have a broad understanding of the scientific and medical issues within the therapeutic areas in which they work, whether they are clinical research associates attempting to accelerate a drug through the drug development pipeline or pharmaceutical sales forces discussing science with physicians and clinicians in the field. The therapeutic areas that GeneEd has addressed represent some of the most critical subject areas in which pharmaceutical employees need comprehensive scientific training.
The new GeneEd Therapeutic
Area curricula include:
Oncology: Introduction to Oncology, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Breast Cancer, Prostate Cancer, Colon Cancer, Melanoma, Liver Cancer, and Stomach Cancer
Urinary System: Anatomy & Physiology and Overactive Bladder.
"The completion of the comprehensive Oncology curriculum, along with the Urinary System curriculum, has allowed GeneEd to deliver the most comprehensive scientific and therapeutic area e-Learning catalog ever assembled." said Salil Patel, Chief Scientific Officer for GeneEd. "These new life science e-Learning courses equip pharmaceutical employees with the scientific knowledge critical to the improvement of job performance, thereby contributing to the health of the pharma organization as a whole. GeneEd is actively responding to the ever-changing training needs of the life science industry, and the introduction of these new therapeutic area curricula in Oncology and the Urinary System reiterates the strength of our science and industry knowledge."
All GeneEd catalog and custom courseware are Continuing Medical Education (CME) Category One accredited and approved. The GeneEd Therapeutic Area E-Learning curricula has also been developed to allow simple technical integration of the courses into a pharmaceutical organization's Learning Management System (LMS), and all GeneEd E-Learning courses are SCORM 1.2 compliant, and have been successfully integrated with 21CFR11-compliant LMS applications.
About GeneEd
GeneEd, Inc. was founded in 1997 to provide life science and healthcare e-learning solutions for the pharmaceutical, biotechnology, instrument and medical device, and hospital/HMO industries. GeneEd's Life Science industry customers include AstraZeneca, Pfizer, the ALZA division of Johnson & Johnson, Celera, Bio-Rad, and IBM Life Sciences, amongst many others. (http://www.geneed.com/clients/index.html)
GeneEd utilizes the best life science content, combined with advanced e-learning development technology, to rapidly create basic and advanced curricula in the areas of genomics, therapeutic area training (for clinical research, product development, and sales and marketing teams), computer assisted drug design, drug discovery and development, pharmacogenomics and clinical genomics, bioinformatics and microarray informatics, and therapeutic and diagnostic products. GeneEd, Inc. is a privately held company headquartered in San Francisco, California. Visit http://www.GeneEd.com for additional information about GeneEd and its courseware.
|
